Deep 6 AI finds patients for clinical trials in minutes rather than months. Using artificial intelligence and natural language processing on clinical data, Deep 6 AI's software accelerates patient recruitment exponentially, getting life-saving treatment to patients more quickly.

Deep Lens is an AI company focused on identifying patients for clinical trials using VIPER, an AI-driven, digital pathology cloud platform which for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.

Inato provides an AI-based data collection tool for the pharmaceutical sector. The tool collects and analyses data for site selection and patient recruitment in clinical trials, helping to accelerate the process and reduce development costs.

Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. Reify Health aims to change how clinical trials are run through its StudyTeam and Care Access platforms. StudyTeam delivers a technology platform for optimizing patient recruitment and enrollment. Care Access, which conducts decentralized trials at scale, is a decentralized research organization that aims to bring clinical trial infrastructure directly to patients, healthcare providers, and communities. Reify Health was founded in 2012 and is based in Boston, Massachusetts.

Belong.Life develops social and professional networks for managing and navigating treatments. The company's mission is to improve the quality of life and quality of care around the world through technology, engagement, data, and AI.

Trialjectory is an AI-based trial matching platform that uses self-reported clinical information to facilitate clinical trial search, matching, and enrollment by cancer patients and their physicians.